This is a preprint.
Multi-omic Biomarkers Distinguish Rheumatoid Arthritis in Discordant Monozygotic Twins
- PMID: 39802798
- PMCID: PMC11722474
- DOI: 10.1101/2024.12.30.24319783
Multi-omic Biomarkers Distinguish Rheumatoid Arthritis in Discordant Monozygotic Twins
Update in
-
Short-chain fatty acids and their gut microbial pathways distinguish rheumatoid arthritis in discordant monozygotic twins.Ann Rheum Dis. 2025 Sep 29:S0003-4967(25)04363-8. doi: 10.1016/j.ard.2025.08.029. Online ahead of print. Ann Rheum Dis. 2025. PMID: 41027803
Abstract
Background: Although genetic factors have been identified in the pathogenesis of rheumatoid arthritis (RA), the concordance rate in monozygotic (MZ) twins is low, suggesting that other features contribute to disease development. Further, the relative contribution of such non-genetic elements in identical twins have not been characterized. Here, we aimed to measure differentiating host and microbial biomarkers of RA by studying MZ twins discordant for disease using a multi-omics approach.
Methods: Eight pairs of MZ twins discordant for RA (n=16) were enrolled. Gut microbiome was assessed using shotgun metagenomic sequencing. Autoantibodies, cytokines, and other plasma proteins were measured in both plasma and feces. Levels of short and medium-chain fatty acids from serum and feces were quantified using gas chromatography mass spectrometry (GC-MS).
Results: While overall microbiome diversity and composition did not significantly differ between twins, we observed a decrease in Blautia faecis in affected twins. Affected twins had higher concentrations of both fecal and plasma citrullinated and non-citrullinated autoantibodies, as well as significantly lower concentrations of fecal butyrate and propionate.
Conclusion: Multi-omics biomarkers differentiate MZ twins discordant for RA. Blautia faecis, which is associated with reduced inflammatory cytokine expression, was decreased in RA twins. Similarly, short-chain fatty acids, known to have immune modulatory effects, were decreased in affected twins, suggesting further bi-directional interactions between inflammation at the gut barrier and disease state. If confirmed in other cohorts, exhaustive multi-omics approaches may improve our understanding of RA pathogenesis and potentially contribute to novel diagnostics and co-adjuvant therapies.
Conflict of interest statement
Competing interests: RBB, KB, WC, IC, AH, RH, RRN, JH, AC, JL, JS, LL, CU, JCC, have no conflicts to declare. JUS has served as a consultant for Janssen, Novartis, Pfizer, Sanofi, Amgen, UCB, BMS, and AbbVie; and has received funding for investigator-initiated studies from Janssen and Pfizer.
Figures
References
-
- Aho K, Koskenvuo M, Tuominen J, Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986;13(5):899–902. (https://www.ncbi.nlm.nih.gov/pubmed/3820198). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous